The EMA “has not yet looked at the data for the fourth dose” of the coronavirus vaccine. “At present, there is no evidence of a need for a fourth dose in the general population.”
Marco Cavaleri, head of vaccines at the European Medicines Agency (EMA), said in a videotaped press conference that repeated “booster doses of the Covid vaccine at very short intervals could reduce the level of antibodies each administration “.
EMA has not yet seen data on the 4th dose. Currently, there is no evidence for the need of a 4th dose in the general population with the current #COVID19vaccines. #EMAPresser
— EU Medicines Agency (@EMA_News) January 18, 2022
“In people with severely weakened immune systems who have already taken three doses, it makes sense for health authorities to consider giving a fourth dose,” Cavaleri said.
According to the EMA, in the future, if we need to take a booster dose, it will be given as soon as the colds catch, as it does with the flu vaccine. Thus, the antibodies will be amplified when needed.
Omicron & other variants: Global regulators agreed that the administration of multiple booster doses at short intervals would not be sustainable in the long term. #COVID19 #EMAPresser #ICMRA
— EU Medicines Agency (@EMA_News) January 18, 2022
In addition, in a review of scientific studies, the EMA “found no increased risk of complications after the Covid mRNA vaccine in pregnancy, miscarriages, preterm births or adverse reactions in unborn children.”
“Vaccines against Covid in pregnancy are safe,” the EMA reiterated after analyzing a detailed review of several studies involving approximately 65,000 pregnancies at different stages.
See all the news here.
Follow Skai.gr on Google News
and be the first to know all the news
.
